166 related articles for article (PubMed ID: 38243867)
21. A clinicopathologic study of 24 cases of systemic mastocytosis involving the gastrointestinal tract and assessment of mucosal mast cell density in irritable bowel syndrome and asymptomatic patients.
Doyle LA; Sepehr GJ; Hamilton MJ; Akin C; Castells MC; Hornick JL
Am J Surg Pathol; 2014 Jun; 38(6):832-43. PubMed ID: 24618605
[TBL] [Abstract][Full Text] [Related]
22. Mutation and methylation status of KIT and TP
Vozdova M; Kubickova S; Fictum P; Cernohorska H; Fröhlich J; Rubes J
Vet Comp Oncol; 2020 Sep; 18(3):438-444. PubMed ID: 31574575
[TBL] [Abstract][Full Text] [Related]
23. Role of imatinib in the treatment of pediatric onset indolent systemic mastocytosis: a case report.
Agarwala MK; George R; Mathews V; Balasubramanian P; Thomas M; Nair S
J Dermatolog Treat; 2013 Dec; 24(6):481-3. PubMed ID: 23659595
[TBL] [Abstract][Full Text] [Related]
24. Mastocytosis in children: a single-center long-term follow-up study.
Popadic S; Lalosevic J; Lekic B; Gajić-Veljic M; Bonaci-Nikolic B; Nikolic M
Int J Dermatol; 2023 May; 62(5):616-620. PubMed ID: 36807903
[TBL] [Abstract][Full Text] [Related]
25. Genotypic and phenotypic characteristics of Chinese neonates with cutaneous mastocytosis: a case report and literature review.
Li Y; Li X; Liu X; Kang L; Liu X
J Int Med Res; 2020 Sep; 48(9):300060520952621. PubMed ID: 32883129
[TBL] [Abstract][Full Text] [Related]
26. Mastocytosis and related entities: a practical roadmap.
Beyens M; Elst J; van der Poorten ML; Van Gasse A; Toscano A; Verlinden A; Vermeulen K; Maes MB; Oude Elberink JNGH; Ebo D; Sabato V
Acta Clin Belg; 2023 Aug; 78(4):325-335. PubMed ID: 36259506
[TBL] [Abstract][Full Text] [Related]
27. The secondary KIT mutation p.Ala510Val in a cutaneous mast cell tumour carrying the activating mutation p.Asn508Ile confers resistance to masitinib in dogs.
Gentilini F; Turba ME; Dally C; Takanosu M; Kurita S; Bonkobara M
BMC Vet Res; 2020 Feb; 16(1):64. PubMed ID: 32075643
[TBL] [Abstract][Full Text] [Related]
28. Validation of dermatopathological criteria to diagnose cutaneous lesions of mastocytosis: importance of KIT D816V mutation analysis.
Gebhard J; Horny HP; Kristensen T; Broesby-Olsen S; Zink A; Biedermann T; Brockow K
J Eur Acad Dermatol Venereol; 2022 Aug; 36(8):1367-1375. PubMed ID: 35412687
[TBL] [Abstract][Full Text] [Related]
29. Cutaneous mast cell tumor with epitheliotropism in 3 dogs.
Oliveira FN; Elliott JW; Lewis BC; Mathews GG; Brown RM; Treadway CM; Langohr IM
Vet Pathol; 2013 Mar; 50(2):234-7. PubMed ID: 22700850
[TBL] [Abstract][Full Text] [Related]
30. c-KIT messenger RNA and protein expression and mutations in canine cutaneous mast cell tumors: correlations with post-surgical prognosis.
Giantin M; Vascellari M; Morello EM; Capello K; Vercelli A; Granato A; Lopparelli RM; Nassuato C; Carminato A; Martano M; Mutinelli F; Dacasto M
J Vet Diagn Invest; 2012 Jan; 24(1):116-26. PubMed ID: 22362941
[TBL] [Abstract][Full Text] [Related]
31. Criteria for the Regression of Pediatric Mastocytosis: A Long-Term Follow-Up.
Polivka L; Rossignol J; Neuraz A; Condé D; Agopian J; Méni C; Garcelon N; Dubreuil P; Maouche-Chrétien L; Hadj-Rabia S; Hermine O; Bodemer C
J Allergy Clin Immunol Pract; 2021 Apr; 9(4):1695-1704.e5. PubMed ID: 33338682
[TBL] [Abstract][Full Text] [Related]
32. An Unusual Transition from Cutaneous to Systemic Mastocytosis in a Pediatric Patient.
Patel K; Cuervo-Pardo L; Cresoe S; Cavero-Chavez V
Pediatr Allergy Immunol Pulmonol; 2023 Dec; 36(4):150-152. PubMed ID: 38134319
[No Abstract] [Full Text] [Related]
33. Standards of Genetic Testing in the Diagnosis and Prognostication of Systemic Mastocytosis in 2022: Recommendations of the EU-US Cooperative Group.
Hoermann G; Sotlar K; Jawhar M; Kristensen T; Bachelot G; Nedoszytko B; Carter MC; Horny HP; Bonadonna P; Sperr WR; Hartmann K; Brockow K; Lyons JJ; Kluin-Nelemans HC; Hermine O; Akin C; Broesby-Olsen S; Triggiani M; Butterfield JH; Schwaab J; Reiter A; Gotlib J; Metcalfe DD; George TI; Orfao A; Valent P; Arock M
J Allergy Clin Immunol Pract; 2022 Aug; 10(8):1953-1963. PubMed ID: 35283331
[TBL] [Abstract][Full Text] [Related]
34. How I treat patients with indolent and smoldering mastocytosis (rare conditions but difficult to manage).
Pardanani A
Blood; 2013 Apr; 121(16):3085-94. PubMed ID: 23426950
[TBL] [Abstract][Full Text] [Related]
35. [Mastocytosis in children].
Wassmer H; Hartmann K
Dermatologie (Heidelb); 2023 May; 74(5):323-329. PubMed ID: 37140636
[TBL] [Abstract][Full Text] [Related]
36. Detection of the KIT D816V mutation in peripheral blood of systemic mastocytosis: diagnostic implications.
Jara-Acevedo M; Teodosio C; Sanchez-Muñoz L; Álvarez-Twose I; Mayado A; Caldas C; Matito A; Morgado JM; Muñoz-González JI; Escribano L; Garcia-Montero AC; Orfao A
Mod Pathol; 2015 Aug; 28(8):1138-49. PubMed ID: 26067933
[TBL] [Abstract][Full Text] [Related]
37. Differential diagnoses of systemic mastocytosis in routinely processed bone marrow biopsy specimens: a review.
Horny HP; Sotlar K; Valent P
Pathobiology; 2010; 77(4):169-80. PubMed ID: 20616612
[TBL] [Abstract][Full Text] [Related]
38. Update on Mastocytosis (Part 1): Pathophysiology, Clinical Features, and Diagnosis.
Azaña JM; Torrelo A; Matito A
Actas Dermosifiliogr; 2016; 107(1):5-14. PubMed ID: 26546030
[TBL] [Abstract][Full Text] [Related]
39. When Mast Cells Run Amok: A Comprehensive Review and Case Study on Severe Neonatal Diffuse Cutaneous Mastocytosis.
Olteanu EG; Bataneant M; Puiu M; Chirita-Emandi A
Genes (Basel); 2023 Oct; 14(11):. PubMed ID: 38002964
[TBL] [Abstract][Full Text] [Related]
40. Cutaneous Mastocytosis in Adults and Children: New Classification and Prognostic Factors.
Matito A; Azaña JM; Torrelo A; Alvarez-Twose I
Immunol Allergy Clin North Am; 2018 Aug; 38(3):351-363. PubMed ID: 30007456
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
